Docoh
Loading...

Andrew Oxtoby

Andrew Oxtoby is Chief Commercial Officer of Aimmune Therapeutics, Inc.

Person profile

Roles
Aimmune Therapeutics Chief Commercial Officer
Address
Brisbane, California
Employees
SEC CIK

Calendar

25 Jan 22
Date Company Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
13 Oct 20 AIMT Aimmune Therapeutics Common Stock, $0.0001 par value Sale back to company Dispose D No No 34.5 20,250 698.63K 0
13 Oct 20 AIMT Aimmune Therapeutics Stock Option Common Stock Sale back to company Dispose D No No 10.69 67,500 721.58K 0
13 Oct 20 AIMT Aimmune Therapeutics Stock Option Common Stock Sale back to company Dispose D No No 12.56 150,000 1.88M 0
10 Oct 20 AIMT Aimmune Therapeutics Common Stock, $0.0001 par value Dispose U No No 34.5 6,345 218.9K 0
15 Sep 20 AIMT Aimmune Therapeutics Common Stock, $0.0001 par value Payment of exercise Dispose F No No 34.25 840 28.77K 26,595

Financial reports

No filings

Current reports

No filings

Registration and prospectus

No filings

Proxies

No filings

Other

No filings